Selling And Administration Expenses Zmiana
Abbott ABT:US $ 2.59B 197M
Abbvie ABBV:US $ 3.09B 254M
ALKERMES ALKS:US 145.78M 18.12M
Amgen AMGN:US $ 1.77B 427M
AstraZeneca AZN:LN 2.63B 357M
Astrazeneca AZN:US 2.63B 357M
Biogen BIIB:US $ 806.2M 233.1M
Bristol Myers Squibb BMY:US $ 2.72B 1.01B
Catalent CTLT:US $ 165.5M 800K
Eli Lilly And LLY:US $ 1.55B 15.2M
Gilead Sciences GILD:US $ 1.73B 624M
GlaxoSmithKline GSK:LN 2.92B 447M
Gw Pharmaceuticals GWPH:US 85.2M 9.31M
JAZZ PHA JAZZ:US 247.17M 39.92M
Johnson & Johnson JNJ:US $ 6.46B 1.03B
Lannett LCI:US $ 13.73M 1.41M
Medtronic MDT:US 2.54B 15M
Novartis NOVN:VX 3.91B 590M
Perrigo Ordinary Shares PRGO:US 280.9M 13.5M
Pfizer PFE:US $ 3.59B 716M
Phibro Animal Health PAHC:US $ 48.38M 56K
Prestige Brands PBH:US $ 59.48M 747K
Regeneron Pharmaceuticals REGN:US $ 303.5M 23.4M
Revance Therapeutics RVNC:US $ 55.82M 7.64M
Teva Pharmaceutical Industries TEVA:US 1.01B 157M
Zoetis ZTS:US $ 520M 96M



Bristol-Myers Squibb Koszty Sprzedaży I Administracji - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2021.